KEFUROX Drug Patent Profile
✉ Email this page to a colleague
When do Kefurox patents expire, and what generic alternatives are available?
Kefurox is a drug marketed by Acs Dobfar and Lilly and is included in three NDAs.
The generic ingredient in KEFUROX is cefuroxime sodium. There are sixty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cefuroxime sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Kefurox
A generic version of KEFUROX was approved as cefuroxime sodium by ACS DOBFAR SPA on May 30th, 1997.
Summary for KEFUROX
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 88 |
| Patent Applications: | 45 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | KEFUROX at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for KEFUROX
US Patents and Regulatory Information for KEFUROX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acs Dobfar | KEFUROX | cefuroxime sodium | INJECTABLE;INJECTION | 062591-002 | Jan 10, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Lilly | KEFUROX IN PLASTIC CONTAINER | cefuroxime sodium | INJECTABLE;INTRAVENOUS | 062590-001 | Jan 10, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Acs Dobfar | KEFUROX | cefuroxime sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 062591-001 | Jan 10, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
